Melchior C. Nierman

1.6k citations

32 papers · 1.1k indexed · 1 hit paper · h-index 15

Cardiology and Cardiovascular Medicine top 5%
Surgery top 10%
Endocrinology, Diabetes and Metabolism top 5%
Molecular Biology
Genetics top 10%

Co-authors: John J.P. Kastelein Erik S.G. Stroes Patrick Duriez Jean‐Charles Fruchart Jan Albert Kuivenhoven Jaap Rip Michael R. Hayden Colin J.D. Ross
Topics: Atrial Fibrillation Management and Outcomes (10 papers)Lipid metabolism and disorders (9 papers)Lipoproteins and Cardiovascular Health (8 papers)
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine
Journals: Circulation Blood Journal of the American College of Cardiology
Partner nations: Netherlands United Kingdom Canada

In The Last Decade

Melchior C. Nierman

27 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

2023 77 citations Sander van Doorn, Melchior C. Nierman et al. profile →

Peers

Countries citing papers authored by Melchior C. Nierman

Since Specialization

Citations

This map shows the geographic impact of Melchior C. Nierman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melchior C. Nierman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melchior C. Nierman more than expected).

Fields of papers citing papers by Melchior C. Nierman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melchior C. Nierman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melchior C. Nierman. The network helps show where Melchior C. Nierman may publish in the future.

Co-authorship network of co-authors of Melchior C. Nierman

This figure shows the co-authorship network connecting the top 25 collaborators of Melchior C. Nierman. A scholar is included among the top collaborators of Melchior C. Nierman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melchior C. Nierman. Melchior C. Nierman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study 2025 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Qingui Chen,Nienke van Rein,Ferdows Atiq,Roger K. Schindhelm,(unknown),C.E.A. Dronkers,(unknown),Arina J. ten Cate‐Hoek,Melchior C. Nierman,Alexander Stork,(unknown),Frederikus A. Klok,Suzanne C. Cannegieter,Marieke J.H.A. Kruip	0
2	YEARS clinical decision rule for diagnosing pulmonary embolism: a prospective diagnostic cohort follow-up study in primary care 2025 ·BMJ Open ·(unknown),(unknown),Frans H. Rutten,Melchior C. Nierman,Frederikus A. Klok,Menno V. Huisman,(unknown),Jeanet W. Blom,Karel G. M. Moons,Geert‐Jan Geersing	0
3	Enhanced identification of familial hypercholesterolemia using central laboratory algorithms 2024 ·Atherosclerosis ·(unknown),Nick S. Nurmohamed,Melchior C. Nierman,(unknown),Linda Zuurbier,Jeroen van Rooij,(unknown),(unknown),G. Kees Hovingh,Laurens F. Reeskamp,Erik S.G. Stroes	1
4	A prospective study investigating the relation between blood‐based biomarkers for Alzheimer’s disease and diagnosis/patient management in primary care: The CANTATE‐PC study 2023 ·Alzheimer s & Dementia ·(unknown),(unknown),Inge M.W. Verberk,Anouk den Braber,(unknown),David Wilson,Melchior C. Nierman,Jurgen Kooren,Wiesje M. van der Flier,Argonde C. van Harten,Charlotte E. Teunissen	0
5	The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists 2023 ·Thrombosis Research ·(unknown),(unknown),Melchior C. Nierman,Menno V. Huisman,(unknown),C. Heleen van Ommen,Marieke J.H.A. Kruip	1
6	ZorgDomein als oplossing bij inclusieproblemen 2023 ·Huisarts en Wetenschap ·(unknown),Frans H. Rutten,Jeanet W. Blom,(unknown),Jochen Cals,Melchior C. Nierman,Geert‐Jan Geersing	0
7	Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis 2021 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Nienke van Rein,F.J.M. van der Meer,Melchior C. Nierman,Willem M. Lijfering,Suzanne C. Cannegieter	4
8	Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study 2021 ·Journal of Thrombosis and Haemostasis ·(unknown),Nienke van Rein,Melchior C. Nierman,(unknown),Menno V. Huisman,F.J.M. van der Meer,Suzanne C. Cannegieter,Willem M. Lijfering	24
9	Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence? 2021 ·Journal of Thrombosis and Haemostasis ·(unknown),Qingui Chen,Marieke J.H.A. Kruip,F.J.M. van der Meer,Melchior C. Nierman,Laura M. Faber,(unknown),Suzanne C. Cannegieter,Willem M. Lijfering	6
10	Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants 2020 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Nienke van Rein,Melchior C. Nierman,(unknown),Menno V. Huisman,F.J.M. van der Meer,Suzanne C. Cannegieter,Willem M. Lijfering	18
11	Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns 2020 ·Journal of Thrombosis and Haemostasis ·(unknown),Nienke van Rein,Melchior C. Nierman,(unknown),Menno V. Huisman,F.J.M. van der Meer,Suzanne C. Cannegieter,Willem M. Lijfering	11
12	Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial 2019 ·BMJ Open ·(unknown),Sander van Doorn,Arno W. Hoes,Melchior C. Nierman,(unknown),Huiberdina L. Koek,Martin E W Hemels,Menno V. Huisman,Kit C. B. Roes,(unknown),(unknown),Frans H. Rutten,Geert‐Jan Geersing	11
13	Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk 2012 ·The American Journal of Cardiology ·Pythia T. Nieuwkerk,Melchior C. Nierman,Maud N. Vissers,(unknown),(unknown),(unknown),John J.P. Kastelein,Mirjam A. G. Sprangers,Hanneke C. de Haes,Erik S.G. Stroes	55
14	Intramuscular Administration of AAV1-Lipoprotein Lipase ^S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients 2008 ·Arteriosclerosis Thrombosis and Vascular Biology ·Erik S.G. Stroes,Melchior C. Nierman,J. J. M. Meulenberg,Remco Franssen,Jaap Twisk,C. P. Henny,Mario Maas,Aeilko H. Zwinderman,Colin J.D. Ross,Eleonora Aronica,Katherine A. High,Marcel M. Levi,Michael R. Hayden,John J.P. Kastelein,Jan Albert Kuivenhoven	145
15	Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia 2006 ·Journal of Lipid Research ·Frank G. Schaap,Melchior C. Nierman,Jimmy F.P. Berbée,Hiroaki Hattori,Philippa J. Talmud,Stefan F.C. Vaessen,Patrick C.N. Rensen,Robert A.F.M. Chamuleau,Jan Albert Kuivenhoven,Albert K. Groen	46
16	Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia 2006 ·Acta Paediatrica ·Anouk van der Graaf,Melchior C. Nierman,Jean Firth,Karen Wolmarans,A. David Marais,Eric de Groot	36
17	Lipoprotein Lipase S447X 2006 ·Arteriosclerosis Thrombosis and Vascular Biology ·Jaap Rip,Melchior C. Nierman,Colin J.D. Ross,J. Wouter Jukema,Michael R. Hayden,John J.P. Kastelein,Erik S.G. Stroes,Jan Albert Kuivenhoven	124
18	Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance 2005 ·Metabolism ·Melchior C. Nierman,Jaap Rip,(unknown),Daniël H. van Raalte,Barbara A. Hutten,Naohiko Sakai,John J.P. Kastelein,Erik S.G. Stroes	21
19	Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention 2005 ·Journal of the American College of Cardiology ·Pascalle S. Monraats,Jamal S. Rana,Melchior C. Nierman,Nuno Pires,Aeilko H. Zwinderman,John J.P. Kastelein,Jan Albert Kuivenhoven,Moniek P.M. de Maat,Saskia Z.H. Rittersma,Abbey Schepers,Pieter A. Doevendans,Robbert J. de Winter,René A. Tio,Rune R. Frants,Paul H.A. Quax,Arnoud van der Laarse,Ernst E. van der Wall,J. Wouter Jukema	8
20	Enhanced Conversion of Triglyceride-Rich Lipoproteins and Increased Low-Density Lipoprotein Removal in LPLS447X Carriers 2005 ·Arteriosclerosis Thrombosis and Vascular Biology ·Melchior C. Nierman,Berthil H.C.M.T. Prinsen,Jaap Rip,Robert Jan Veldman,Jan Albert Kuivenhoven,John J.P. Kastelein,Monique G.M. de Sain–van der Velden,Erik S.G. Stroes	19

About Melchior C. Nierman

Melchior C. Nierman is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Internal Medicine, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (10 papers), Lipid metabolism and disorders (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (542 citations), Endocrinology, Diabetes and Metabolism (325 citations) and Internal Medicine (65 citations). Melchior C. Nierman has collaborated with scholars based in Netherlands, United Kingdom and Canada. Frequent co-authors include John J.P. Kastelein, Erik S.G. Stroes, Patrick Duriez, Jean‐Charles Fruchart, Jan Albert Kuivenhoven, Jaap Rip, Michael R. Hayden, Colin J.D. Ross, J. Wouter Jukema and Jaap Twisk. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact